Table 3 Summary of the worst-case target coverage as percentage of prescription dose
From: A single-field integrated boost treatment planning technique for spot scanning proton therapy
| Â | SFUD% (range) | SFIB% (range) | IMPT% (range) |
|---|---|---|---|
D 95 /D pre (All patients) | 102.7 ± 5.0 | 100 ± 1.3 | - |
(97.6-115.9) | (97.6-102.5) | - | |
D 98 /D pre (All patients) | 101.1 ± 5.2 | 98.1 ± 2.1 | - |
(95.2-114.2) | (95.0-101.2) | - | |
EUD/D pre (All patients) | 108.0 ± 6.1 | 104.6 ± 2.8 | - |
(101.6-120.2) | (101.9-108.9) | - | |
D 95 /D pre (exclude patient 2) | 103.8 ± 5.5 | 100.1 ± 1.5 | 97.4 ± 3.3 |
(99.7-115.9) | (97.6-102.5) | (92.7-101.9) | |
D 98 /D pre (exclude patient 2) | 101.9 ± 5.9 | 97.9 ± 2.4 | 93.6 ± 6.1 |
(95.2-114.2) | (95.0-101.2) | (82.4-100.4) | |
EUD/D pre (exclude patient 2) | 109.5 ± 6.7 | 105.5 ± 3.0 | 102.3 ± 4.1 |
(101.6-120.2) | (101.9-108.9) | (95.4-106.8) |